Revolutionizing Cancer Care: The Quadra PET Scanner's Impact on Patients and Research
A Game-Changer for Cancer Patients: Faster, More Precise Scanning
Imagine undergoing scans that are not only quicker but also more comfortable and precise. This is the reality for patients like Karen, who has been diagnosed with both multiple sclerosis and metastatic melanoma. Every three months, she endures lengthy MRI and PET scans, but now, with the arrival of the Quadra PET scanner, her experience is about to change dramatically.
The Quadra, one of the most advanced scanners of its kind globally, has reduced Karen's scan time from over 35 minutes to under 10 minutes. But the benefits don't stop there. The new scanner operates at a lower radiation dose than previous PET/CT scanners, providing patients with a safer and more comfortable experience.
"I feel very fortunate to have access to this cutting-edge technology," Karen shares. "It's reassuring to know that the doctors can get more detailed information, especially when so much is still unknown about my condition."
A Win-Win for Patients and Healthcare Providers
The impact of the Quadra extends beyond individual patients. For A/Prof Andrew Haydon, Karen's oncologist at The Alfred, the scanner allows for more efficient patient care. "Having this technology on-site means we can see more patients in a more timely manner, ultimately helping them get the care they need faster," he explains.
The Quadra also enables healthcare providers to track the body's response in near-real time, allowing them to identify what's working and what's not, and even potential side effects, sooner than ever before. This leads to better outcomes and more effective treatment plans.
Advancing Cancer Diagnosis and Treatment
For A/Prof Ken Yap, Director of Nuclear Medicine and PET at The Alfred, the Quadra's ability to give valuable time back to patients is a significant benefit. "We don't want patients to spend any longer at the hospital than they need to," he says. "The fact that we can now cut down on scan times while also increasing safety and comfort is a positive step forward."
The Quadra scanner is not just about improving patient experiences; it's also about advancing cancer diagnosis and treatment. "This incredible technology will further enable us to match therapies to individual tumour biology, which is our work in theranostics, and continue to break new ground in terms of clinical trials," A/Prof Yap adds.
A Collaborative Effort
The development of the Quadra PET scanner was made possible through a $24 million investment, jointly funded by the Federal Government ($12 million), Victorian Government ($7 million), and philanthropic support through The Alfred Foundation ($5 million). This collaboration has paved the way for a brighter future in cancer care, where patients can expect faster, more precise, and safer scanning experiences, and healthcare providers can continue to push the boundaries of cancer diagnosis and treatment.
